Back

Correction to: Outcomes of simplified left atrial appendage occlusion using the WATCHMAN FLX device: the ROSE-FLX study

EP Europace Journal

16 October 2026
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Interventional left atrial appendage occlusion is effective and safe in high-risk patients with prior stroke: comprehensive insights from the multicenter German LAARGE registry
26 August 2023
thumbnail
Congress Presentation
The predictive value of compression rate on residual leak after left atrial appendage occlusion with watchman FLX
28 August 2023
thumbnail
Congress Presentation
Safety and healthcare resource utilisation in patients undergoing left-atrial appendage closure - A nationwide analysis.
28 August 2023
thumbnail
Congress Presentation
3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial
1 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources